1. Home
  2. NYXH vs VWAV Comparison

NYXH vs VWAV Comparison

Compare NYXH & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$4.46

Market Cap

188.1M

Sector

Health Care

ML Signal

HOLD

VWAV

VisionWave Holdings Inc.

N/A

Current Price

$8.70

Market Cap

155.4M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NYXH
VWAV
Founded
2009
2024
Country
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
188.1M
155.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NYXH
VWAV
Price
$4.46
$8.70
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.67
N/A
AVG Volume (30 Days)
47.3K
223.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$97.32
N/A
Revenue Next Year
$241.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$2.06
52 Week High
$11.87
$18.41

Technical Indicators

Market Signals
Indicator
NYXH
VWAV
Relative Strength Index (RSI) 52.06 41.63
Support Level $4.36 $7.80
Resistance Level $4.83 $9.00
Average True Range (ATR) 0.17 0.82
MACD -0.01 -0.12
Stochastic Oscillator 74.88 28.19

Price Performance

Historical Comparison
NYXH
VWAV

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

Share on Social Networks: